Bladder Cancer Subject of New Actos Lawsuit
Actos is a drug manufactured by Takeda Pharmaceuticals that was approved by the FDA in 1999 for the treatment of type 2 diabetes. The European Medicines Agency approved the drug the following year. Though a possible link to bladder cancer arose in 2005 clinical trials,... Read More